Antisynthetase Syndrome (Anti-EJ/glycyl-tRNA synthetase)
Imaging findings
Initial chest CT shows extensive, bilateral, and multi-lobar ground-glass opacities and consolidations, primarily concentrated in the lower lung zones. Follow-up CT performed several months later shows a significant decrease in active consolidative opacities, but with residual reticulation, traction bronchiectasis, and architectural distortion at the lung bases, representing evolving fibrotic interstitial lung disease.
Key takeaways
Antisynthetase syndrome is an autoimmune, myositis-associated interstitial lung disease (ILD) that can be linked to multiple anti-aminoacyl-tRNA synthetase antibodies, including anti-Jo-1, anti-PL-7, anti-PL-12, and anti-EJ. Patients frequently present with acute or subacute respiratory symptoms mimicking community-acquired pneumonia, with underlying histopathology typically showing a combination of organizing pneumonia (OP) and non-specific interstitial pneumonia (NSIP).
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Explosive Pleuritis (Streptococcus anginosus Empyema)Infection
- Traumatic Right Hemidiaphragm RuptureTrauma
- Antisynthetase Syndrome (Anti-Jo-1)ILD
- Bilateral Diaphragmatic Paralysis Post-Heart TransplantIatrogenic
- Mycobacterium xenopi Pulmonary Infection with Chest Wall InvasionInfection
- Naganishia (Cryptococcus) Pulmonary InfectionInfection
- Left Lower Lobe Atelectasis secondary to Bronchial CarcinoidNeoplastic
- Small Cell Lung Carcinoma (with Atypical Popcorn Calcification)Neoplastic
See all cases from September 6, 2021 →
Related ILD cases
- Lupus-Associated Interstitial Lung Disease (Fibrotic NSIP with Cystic Changes)
- Recurrent Lymphangioleiomyomatosis (LAM) Post-Lung Transplant
- Resolving Post-COVID Diffuse Alveolar Damage
- Non-Specific Interstitial Pneumonia (NSIP)
- Surfactant Protein C Mutation-Associated Pulmonary Fibrosis
- Scleroderma-Associated Non-Specific Interstitial Pneumonia (NSIP)